(Q22252709)

Dimensions Publication ID

Dimensions

1043348790

Progression of Parkinson's disease without levodopa

6 February 2023

language of work or name

English

0 references

publication date

December 2006

0 references

published in

Journal of Neurology

0 references

volume

253

0 references

issue

S7

0 references

page(s)

vii2-vii6

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-7002-7

Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-7002-7

Risk factors for nursing home placement in advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-7002-7

Frequency of bowel movements and the future risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-7002-7

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-7002-7

Mortality from Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-7002-7

Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential i

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-7002-7

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

12 December 2020

Mortality of patients with parkinson's disease treated with levodopa

1 reference

12 December 2020

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations

1 reference

12 December 2020

Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.

1 reference

12 December 2020

Low-dose L-dopa therapy in Parkinson's disease: a 6-year follow-up study

1 reference

12 December 2020

A systematic review of prevalence studies of dementia in Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years

1 reference

12 December 2020

Levodopa and the progression of Parkinson's disease

1 reference

12 December 2020

A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease

1 reference

12 December 2020

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

1 reference

12 December 2020

The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years

1 reference

12 December 2020

Clinical observations on the rate of progression of idiopathic parkinsonism

1 reference

12 December 2020

Effect of lazabemide on the progression of disability in early Parkinson's disease. The Parkinson Study Group.

1 reference

12 December 2020

Association between early-onset Parkinson's disease and mutations in the parkin gene

1 reference

12 December 2020

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

12 December 2020

Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease.

1 reference

12 December 2020

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

1 reference

12 December 2020

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

12 December 2020

Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders

1 reference

12 December 2020

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

12 December 2020